Sarepta Therapeutics Other Long Term Liabilities (Quarterly) Insights

Sarepta Therapeutics, Inc. (SRPT)

18.92 +0.04 (+0.21%) USD | NASDAQ | Feb 23, 09:37

View Other Long Term Liabilities (Quarterly) for SRPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Arrowhead Pharmaceuticals, Inc.	--
Merck & Co., Inc.	Upgrade
Pfizer Inc.	Upgrade
REGENXBIO, Inc.	Upgrade
Keros Therapeutics, Inc.	--